1-2 of 2
Authors: Henrik Maagensen
Sort by
Journal Article
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes
Get access
Sofie Hædersdal and others
European Journal of Endocrinology, Volume 187, Issue 4, Oct 2022, Pages 507–518, https://doi.org/10.1530/EJE-22-0291
Published: 16 September 2022
Journal Article
The glucagon receptor antagonist LY2409021 has no effect on postprandial glucose in type 2 diabetes
Get access
Sofie Hædersdal and others
European Journal of Endocrinology, Volume 186, Issue 2, Feb 2022, Pages 207–221, https://doi.org/10.1530/EJE-21-0865
Published: 06 January 2022
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals